Progress 03/01/05 to 12/31/06
Outputs We were able to study two groups of cats and their response to a uniform Bermuda grass allergen (BGA) sensitization and challenge protocol to induce an asthmatic phenotype. Group I cats (n=20) were obtained from an outside vendor, and Group II cats (n=12) were bred at UMC using high responder asthmatic cats (one male, two females) that the PI brought from UC Davis with her as a breeding colony. All 32 cats were housed in an identical environment, albeit over different time frames. After BGA sensitization/challenge, cats were categorized as high responders (HR; plus IgE, bronchoalveolar lavage fluid (BALF) eosinophils greater than 30% AND presence of clinical signs after BGA aerosol), low responders (LR; plus/minus IgE, BALF eosinophils greater than 30% OR presence of clinical signs after BGA aerosol), or non responders (NR; plus/minus IgE, BALF eosinophils greater than 30% AND no clinical signs after BGA aerosol.
Impacts This project documented that the asthmatic breeding colony established at UMC produces offspring that have a more profound asthmatic phenotype superior for asthma research that commercially purchased cats. Results of this study showed that there are some differences between cellular and cytokine responses in high responder versus low responder asthmatic cats. In particular, allergen-specific lymphocyte blastogenesis assays showed more reactivity and IL-4 concentrations from BALF supernatant samples were comparatively higher in higher responder cats. These in vitro assays will be useful in future studies to help determine how the aberrant allergic response is altered with a variety of immunomodulatory strategies.
Publications
- No publications reported this period
|
Progress 01/01/05 to 12/31/05
Outputs : To date, 9 cats have been studied, and therefore the summary will be presented as pilot data only in descriptive form. At baseline (ie, prior to sensitization and challenge with allergen), the mean+/-SD of the bronchoalveolar lavage (BALF) eosinophil percentage was 2.5+/-1.7 (range, 1-5); after exposure to allergen, it was 56+/-14 (range, 32-74). Results of intradermal skin testing (IDST) at baseline showed no cat had skin reactivity; after induction of asthma, cats were again tested for positive skin reactivity (defined as >50% between the diameters of the positive (histamine) and negative (saline) controls. Two cats were non-responders (wheals were the same size or smaller than the negative control), and the remainder of the cats had positive skin reactivity. After becoming asthmatic, serum allergen specific IgE levels increased to 173+/-89 (range, 40-293; expressed as a percentage of a positive pooled control). Clinical signs related to bronchoconstriction were
mild in all cats. The percentage of CD4+CD25+ Tregulatory (Tregs) cells detected in the peripheral blood were 3.6+/-0.5 (range, 3.0-4.6), which is lower than reported for healthy cats (5-10%). Cytokine assays are pending. We are continuing to enroll additional cats to increase the power of the study, so that we can group cats according to their phenotype as non-, low- or high-responders and attempt to correlate the phenotype with the percentage of Tregs and immunosuppressive cytokines levels (in particular, IL-10).
Impacts The cat is the only animal species that naturally and commonly develops a syndrome of asthma that is remarkably similar to the human disease. Therefore, the cat makes an excellent model to study the immunologic and pathophysiologic mechanisms of asthma. We are attempting to determine if the inability to develop peripheral tolerance is associated with the severity of the asthmatic phenotype. If so, future studies can be directed towards looking at factors which prevent tolerance development as well as therapeutic modalities which can enhance development of tolerance.
Publications
- No publications reported this period
|
|